Ergoteles LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$416,883
-7.7%
2,947
+9.9%
0.02%
+11.1%
Q1 2023$451,542
-69.3%
2,682
-51.7%
0.02%
-68.4%
Q4 2021$1,470,000
-91.1%
5,549
-90.3%
0.06%
-90.6%
Q3 2021$16,487,000
+5201.3%
57,052
+3564.2%
0.60%
+8528.6%
Q2 2021$311,000
-87.6%
1,557
-88.1%
0.01%
-91.6%
Q4 2020$2,517,00013,1340.08%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders